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Protein dynamicsAMP-activated protein kinase (AMPK) is a key energy sensor regulating the cell metabolism in response
to energy supply and demand. The evolutionary adaptation of AMPK to different tissues is accomplished
through the expression of distinct isoforms that can form up to 12 complexes, which exhibit notable dif-
ferences in the sensitivity to allosteric activators. To shed light into the molecular determinants of the
allosteric regulation of this energy sensor, we have examined the structural and dynamical properties
of b1- and b2-containing AMPK complexes formed with small molecule activators A-769662 and SC4,
and dissected the mechanical response leading to active-like enzyme conformations through the analysis
of interaction networks between structural domains. The results reveal the mechanical sensitivity of the
a2b1 complex, in contrast with a larger resilience of the a2b2 species, especially regarding modulation by
A-769662. Furthermore, binding of activators to a2b1 consistently promotes the pre-organization of the
ATP-binding site, favoring the adoption of activated states of the enzyme. These findings are discussed in
light of the changes in the residue content of b-subunit isoforms, particularly regarding the
b1Asn111 ? b2Asp111 substitution as a key factor in modulating the mechanical sensitivity of b1-
and b2-containing AMPK complexes. Our studies pave the way for the design of activators tailored for
improving the therapeutic treatment of tissue-specific metabolic disorders.
 2021 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and
Structural Biotechnology. This is an open access article under the CC BY-NC-ND license (http://creative-
commons.org/licenses/by-nc-nd/4.0/).1. Introduction
Protein isoforms provide complexity to the structural and func-
tional space of the human proteome [1]. Diverse mechanisms, such
as genetic changes in protein-coding regions, alternative splicing
and post-translational alterations, mediate the formation of iso-
forms, enriching the functional diversity by modulating enzymatic
activities, molecular interactions and subcellular localizations [2,3]
In this context, disclosing the molecular basis of the structural vari-
ation between isoforms is critical for understanding their func-
tional adaptation to different tissues and organs, and for the
design of therapeutic approaches tailored to the spatio-temporal
context of diseases [4–7].The evolutionary adaptation of protein isoforms is a key aspect
of mammalian adenosine monophosphate-activated protein kinase
(AMPK), which can form up to 12 different combinations according
to the tissue-dependent expression of isoforms identified for the
three structural components required for full activity [8–10]. This
can be understood from the role played as a fuel-sensing enzyme
in preserving the cellular energy homeostasis [11,12], since AMPK
activation reduces the rate of anabolic pathways and up-regulates
catabolic processes, resulting in increased levels of ATP. Further-
more, AMPK is implicated in metabolic disorders such as obesity
and type 2 diabetes, cardiovascular diseases and cancer [13–15],
attracting widespread interest as a therapeutic target [16].
AMPK is a heterotrimeric complex consisting of a catalytic a-
subunit and two regulatory (b and c) components, which are
encoded by multiple genes, including two a (a1, a2), two b (b1,
b2), and three c (c1, c2, c3) isoforms [17,18]. The catalytic subunit
has a Ser/Thr kinase domain at the N-terminus and its C-terminus
is necessary for the formation of the complex with the other com-
ponents. The b-subunit has a central carbohydrate-binding module
(CBM) that mediates AMPK interaction with glycogen, and the C-
terminal region acts as a scaffold for the heterotrimeric assembly.
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synthase (CBS) domain and contains four adenine nucleotide bind-
ing sites, which mediate the allosteric activation of the kinase
activity by AMP, enabling AMPK to react to subtle fluctuations in
the AMP/ATP ratio [19,20].
Due to its role in energy homeostasis, AMPK is finely regulated
by different mechanisms [10], such as phosphorylation of
a2Thr172 in the activation loop of the kinase domain. Thus, bind-
ing of AMP to the c-subunit, in conjunction with Thr172 phospho-
rylation by upstream kinases such as LKB1 and CaMKKb, converts
the inactive enzyme into an active species, which is several
thousand-fold more active [20,21]. AMPK can also be indirectly
activated by compounds such as metformin, phenformin and oly-
gomycin [22], which increase the intracellular levels of AMP.
Finally, a direct activation of AMPK can be triggered by modulators
such as the thienopyridone drug A-769662 (Table 1) [23], which
binds to the so-called allosteric drug and metabolite (ADaM) site
located at the interface between a- and b-subunits [24,25], pro-
moting an activation mechanism independent of Thr172 phospho-
rylation. Indeed, binding of A-769662 can increase the AMPK
activity >90-fold when Ser108 in the CBM domain of the b-
subunit is phosphorylated [26], and may also protect against
dephosphorylation of Thr172 [21].
Several direct AMPK activators have been reported in the last
few years, showing in some cases a marked isoform selectivity,
[27] as can be noticed upon inspection of the biochemical data
collected in Table 1 for selected small molecule AMPK activators.
A-769662 is active in a2b1c1 but not in a2b2c1, at least up to
concentrations of 10 lM [24], demonstrating selectivity toward
b1-containing AMPK complexes. Likewise, the enzyme activation
is ~7-fold larger in a2b1c1 relative to a2b2c1. A mild
b1-selective activation is found for 991 and SC4, as they activate
b1- and b2-containing AMPK complexes, although a higher
(~2-fold) activation is observed in the former case [24,28,29].
The activation also seems to be slightly larger for the enzyme
containing the a2 isoform. While PF-249 is an activator selective
for b1-containing complexes, PF-739 is a pan-activator that acti-
vates a2b1c1 and a2b2c1 complexes, though it still exhibits a
larger affinity for the b1-containing isoforms (EC50 ratio of ~ 8
and ~ 15 between a2b1c1/a2b2c1 and a1b1c1/a1b2c1, respec-
tively) [30]. PF-739 seems also to have a larger effect on the
a2-containing AMPK complexes, as the ratio of the EC50 values
is 1.8–3.2 larger for a1b1c1 and a1b2c1 relative to the
a2-containing enzymes. Finally, MT47-100, a structural analogue
of A-769662 possessing a dihydroquinoline ring instead of the
thienopyridone core, activates both a1b1c1 and a2b1c1, but pro-
motes the inhibition of b2-containing complexes [31].
Understanding the molecular mechanisms that underlie the
regulatory effect of direct activators, particularly targeting selec-
tively a given isoform, is of utmost relevance for gaining insight
into the puzzling tissue-dependent modulation of AMPK, and to
disclose drugs active against specific pathological disorders. Given
the sensitivity of the AMPK enzyme to the precise combination of
different isoforms, as exemplified by the distinctive trends
observed in the activation of complexes with a1/a2 and b1/b2 iso-
forms (see above), we have adopted a ’divide-and-conquer’ strat-
egy in order to explore the molecular basis of the selective
isoform activation of AMPK, specifically focusing on the role played
by b1- and b2-subunits. To this end, extended molecular dynamics
(MD) simulations have been performed for the apo forms, the holo
complexes formed with A-769662 and SC4 bound to the ADaM
site, and the ternary (holo + ATP) complexes formed by the enzyme
bound to both activator (in the ADaM site) and ATP (in the ATP-
binding site). The analysis of the structural and dynamical proper-
ties of AMPK complexes and the identification of the interaction
networks between a- and b-subunits have unveiled distinctive3395molecular determinants of the allosteric regulation exerted by
direct activators on b1- and b2-containing enzymes.2. Material and methods
2.1. Molecular dynamics simulations
Extended molecular dynamics (MD) simulations were utilized
to analyze the structural and dynamical characteristics of the sim-
ulated system. For this purpose, the a2b1c1 systems were built up
using the complexes with A-769662 (PDB entry 4CFF) [24] and SC4
(PDB entry 6B1U) [29]. On the other hand, the system related to the
complex of a2b2c1 bound to SC4 (PDB entry 6B2E) [29] was also
used as a template to model the complexes with A-769662. Fol-
lowing our previous studies [32], the c-subunit was not considered
in MD simulations due to several reasons. First, the ADaM site is
shaped only by a- and b-isoforms. Furthermore, the lack of precise
structural information about stretches of both a- and b-subunits,
particularly regarding the C-terminal regions, which are located
close to the c-subunit, would introduce an additional level of
uncertainty, opening the way to potential artefacts in the simula-
tions. Finally, inclusion of the c-subunit would have required a lar-
ger computational cost in order to guarantee a proper sampling of
the dynamical motions of the three isoforms. Accordingly, follow-
ing the ’divide-and-conquer’ strategy outlined above, the simu-
lated systems comprise only a- and b-subunits. Specifically,
simulations were performed for residues 8–278 of the a2 isoform,
and residues 78–173 and 77–171 of the b1- and b2-isoforms,
which were solved without disruptions in the X-ray structures.
Finally, these structures were used to model the apo protein, the
complexes of the activators bound to the phosphorylated Ser108
(pSer108)-containing isoforms (holo), and the corresponding
holo + ATP complexes with both activator in the ADaM site and
ATP in the ATP-binding site.
Simulations were performed using the AMBER18 package [33]
and the Amber ff99SB-ILDN force field [34] for the protein, whereas
the ligands (A-769662, SC4) were parameterized using the GAFF
[35] force field in conjunction with restrained electrostatic
potential-fitted (RESP) partial atomic charges derived from
B3LYP/6-31G(d) calculations [36]. The standard protonation state
at physiological pH was assigned to ionisable residues, and a cap-
ping group (N-methyl) was added to the C-terminus of the a-
subunit. The simulated systems were immersed in an octahedral
box of TIP3P water molecules [37]. Counterions atoms were added
to maintain the neutrality of the simulated systems [38]. The final
systems included the AMPK protein, around 25,000–28,000 water
molecules, and a variable number of Na+ and Cl- ions, leading to
simulated systems that contain between 81,000–90,000 atoms
(specific details are given in Table S1).
Simulations were performed in the NPT ensemble for equilibra-
tion and NVT for MD productions using periodic boundary condi-
tions and Ewald sums (grid spacing 1 Å) for treating long-range
electrostatic interactions. Apo, holo and holo + ATP systems were
simulated in triplicate. The minimization of the systems was per-
formed refining the position of hydrogen atoms in the protein
(2000 cycles of steepest descent algorithm followed by 8000 cycles
of conjugate gradient), subsequently minimizing the position of
water molecules (using again the previous scheme), and finally
minimization of the whole system (4000 cycles for steepest des-
cent and 1000 cycles of conjugate gradient). Later, the temperature
of the system was gradually raised from 100 to 300 K in 5 steps,
50 ps each using the NVT ensemble. In this process, suitable
restraints (5 kcal mol1 Å2) were imposed to keep the ligand (ac-
tivator, ATP) in the binding pocket and prevent artefactual rear-
rangements along the equilibration stage. In order to equilibrate
Table 1
Activation of AMPK isoforms by selected direct activators.
Activator Property a Isoform
a2b1c1 a2b2c1 a1b1c1 a1b2c1
A-769662
Activation fold b 14.3 NA c 2.0 NA c
Kd (lM) b 0.40 — 0.51 14.5
991













Activation fold g 5.2 2.9 2.4 1.2
EC50 (nM) g — 17.2 5.1 —
PF-249
EC50 (nM) h 8.04 > 40 lM 9.37 > 40 lM
PF-739
EC50 (nM) h 5.23 42.4 8.99 136
MT47-100
Activation fold i 2.3 0.5 2.5 0.4
a Activation fold measured relative to the basal activity of the enzyme. Dashed lines stand for systems were no experimental data have been reported, to the best of our
knowledge. b Ref 24. c No activation detected up to a concentration of 10 lM. d Ref. 28. e Determined for a2b1c2. f Values obtained by using either biolayer interferometry or
circular dichroism. g Ref. 29. h Ref. 30. i Ref. 31.
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NPT ensemble. In addition, the restraints were progressively elim-
inated in this later step. Production MD simulations were run for
1 ls per replica, leading to a total simulation time of 24 ls for
the ligand-bound AMPK complexes, and 6 ls for the two apo spe-
cies of AMPK.
2.2. Essential dynamics
This method was utilized to specify the most important
motions from the structural variance sampled in MD simulations.
In essential dynamics (ED) [39], the dynamics along the individ-
ual modes can be studied and visualized separately, so we can fil-
ter the main collective motions during our simulations.
Therefore, the positional covariance matrix is created and diago-
nalized in order to achieve the collective deformation modes, i.e.
the eigenvectors, while the eigenvalues account for the contribu-
tion of each motion to the structural variance of the protein. ED
analysis was done for 25,000 snapshots from the last 500 ns of
each simulation, taking into account only the backbone atoms
and the calculations were performed with PCAsuite program
(available at http://www.mmb.irbbarcelona.org/software/pca-
suite/pcasuite.html), which is integrated in the pyPCcazip pro-
gram, a suite of tools for compression and analysis of molecular
simulations [40].33962.3. Conformational entropy
The quasi-harmonic approximation proposed by Schlitter [41]
was used to calculate the conformational entropy sampled for
the different simulation systems. Due to the sensitivity of these
calculations to simulation time and sampling [42], the conforma-
tional entropy determined at regular interval times (S(t)) along
the MD simulation was used to estimate the conformational
entropy at infinite time (S1) [43]. In particular, S1was determined
by fitting the asymptotic behaviour of the curve according to the
expression S tð Þ ¼ S1 ttþa, where a is an adjustable parameter by
curve fitting. In order to enable a direct comparison between the
conformational entropies of the different a2b1 and a2b2 systems,
only the set of atoms of the protein backbone were considered in
entropy calculations, thus avoiding a bias originated from the resi-
due substitutions between b1- and b2-isoforms in the calculated
entropies (note that a different choice of atoms, including both
backbone and side chains, was used in the comparison of the con-
formational entropies reported for a2b1 bound to A-769662 in a
previous study [32]).
2.4. Dynamical cross-correlation analysis
To complement the information gained from the ED analysis,
dynamical cross-correlation (DCC) was used to examine the corre-
Fig. 1. A) Superposition of the energy-minimized averaged holo + ATP structures for a2b1 and a2b2 complexes with A-769662 and SC4 (ligands are not shown for the sake of
clarity). The backbone of a and b subunits is shown as green and blue cartoon, respectively (P-loop highlighted in yellow). The X-ray structures of a2b1 and a2b2 (PDB IDs
4CFF and 6B2E, respectively) are shown in magenta cartoon. B) RMSF (Å) average of the residues determined along the last 500 ns of the three independent replicas run for
apo (red), holo and holo + ATP (green and black, respectively). Complexes bound to A-769662 and SC4 are shown in middle and bottom panels. The highlighted bars denote
regions corresponding to P-loop (purple), activation loop (cyan), CBM domain (orange), and C-interacting helix (green). (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.)
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the snapshots were aligned by means of least-square fitting of
Ca atoms of the whole protein to the equilibrated starting configu-
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where the position vectors of two Ca atoms i and j fitted in the
structure at time t are denoted as ri(t) and rj(t), respectively.
The cross-correlation coefficients range from 1 to + 1, which
represent anticorrelated and correlated motions, respectively,
whereas values close to zero indicate the absence of correlated
motions [44]. This analysis was performed using the module avail-
able in AMBER package. The similarity between the DCC matrices
computed for the three replicas run for apo, holo and holo + ATP
systems was estimated using the Tanimoto similarity index [45].
This parameter is a distance metrics used to quantify the degree
of similarity between two sets of data. While this index is widely
adopted to compare the descriptors that characterize the chemical
structure of molecules, in this study it is used to compare the cor-
related motions determined for pairs of residues in the AMPK
complexes.2.5. Interaction energy network
Networks of local interactions are intrinsically linked to the
structural response of proteins to external factors [46]. For our pur-
poses, Weighted Implementation of Suboptimal Path (WISP) [47]
was utilized to analyze the allosteric network. This method
enabled us to perform a dynamic network analysis to understand
how the binding of a ligand in an allosteric cavity could affect
another binding site. In particular, WISP relies on the dynamical
interdependence among the protein residues. To this end, each
amino acid is treated as a node, which was located at the residue
center-of-mass, and the interdependence among nodes is repre-
sented as a connecting edge with an associated numeric value that
reflects its strength. The interdependence is determined from an
NxN matrix C (N is the number of nodes) with values correspond-
ing to the weights of each edge, reflecting the correlated motion
among node–node pairs. Finally, the weight between the edge that
connects nodes i and j is expressed as wij ¼ logð Cij
 Þ, so that
highly correlated or anticorrelated motions are characterized by
small values of wij. This analysis was performed for the last
500 ns of the MD simulations.Table 2
RMSD and standard deviation (Å) determined for the protein backbone of the snapshots sam
holo + ATP states of AMPK isoforms a2b1 and a2b2). Values were determined using the e
system as reference structure.
Activator System Replica 1
a2b1
A-769662 apo 2.5 ± 0.5
holo 2.3 ± 0.4
holo + ATP 1.9 ± 0.2
SC4 apo 3.2 ± 0.5
holo 2.9 ± 0.4
holo + ATP 2.0 ± 0.2
a2b2
A-769662 apo 2.7 ± 0.3
holo 4.2 ± 0.5
holo + ATP 2.1 ± 0.2
SC4 apo 3.0 ± 0.3
holo 3.3 ± 0.3
holo + ATP 2.3 ± 0.2
33983. Results
MD simulations were performed to examine the structural and
dynamical changes triggered by A-769662 and SC4 through the
analysis of the apo form of AMPK considering both a2b1 and
a2b2 isoforms, and their holo and holo + ATP complexes, as well
as the interaction networks implicated in the dynamical response
to activator binding. Three independent replicas (1 ls/replica)
were run for each system, leading to a total simulation time of
6 ls for the apo species and 24 ls for the ligand-bound complexes.
3.1. Global structural analysis of AMPK complexes
The effect of activator and ATP binding on the structural fea-
tures of AMPK complexes was examined from the positional
root-mean square deviation (RMSD) of the protein backbone along
the simulation. The average structure of the holo + ATP species
sampled in the last 200 ns of the three simulations run for each
activator was used as reference. There is a large structural resem-
blance between the averaged holo + ATP species, as noted in the
superposition of the protein backbone for the complexes of a2b1
(Fig. 1A left) and a2b2 (Fig. 1A right) bound to ATP and either A-
769662 or SC4. The structural resemblance of the energy-
minimized averaged holo + ATP structures is also noted in RMSD
values of 0.8–1.6 Å, which supports the preservation of the overall
fold of the protein upon binding of both activator and ATP. Preser-
vation of the overall structure of holo + ATP complexes is also sup-
ported by the small fluctuations observed in RMSD profiles (Fig. S1
and S2), as noted by the values of 1.9–2.3 Å for a2b1 and 1.9–2.7 Å
for a2b2 (Table 2). For the a2b1 systems, the RMSD of the sampled
structures is reduced from apo (2.5–3.2 Å) to holo (1.9–2.9 Å) to
holo + ATP (1.9–2.3 Å), revealing that binding of activator and
ATP stabilizes the overall fold of the complex (Table 2). This effect
is less apparent for the a2b2 complexes, as the RMSD values of the
apo species (2.7–3.9 Å) are similar or even lower than those deter-
mined for the holo form (2.9–4.5 Å), suggesting that the activator
exerts a weaker structural stabilization upon binding to a2b2
isoform.
On the other hand, the per-residue mean square fluctuation
(RMSF) profile is similar for the two isoforms, as noted in the
resemblance of the fluctuation pattern obtained by averaging the
RMSF of the three replicas run for every system (Fig. 1B). The high-
est fluctuations in the a-subunit mainly originate from residues in
the activation loop (residues 165–185) and the a-helix between
residues 210–230. The largest fluctuations in the b-subunit corre-
spond to residues in the CBM domain, which contains Ser108,
and regions proximal to the C-interacting helix. Compared to thepled along the last 500 ns of MD simulations performed for all systems (apo, holo and
nergy-minimized holo + ATP species averaged for the last 200 ns of each simulation
Replica 2 Replica 3 Average
3.1 ± 0.6 2.6 ± 0.3 2.7
1.9 ± 0.3 2.2 ± 0.3 2.1
2.0 ± 0.3 1.9 ± 0.2 1.9
2.9 ± 0.5 3.1 ± 0.4 3.1
2.2 ± 0.3 2.3 ± 0.6 2.5
2.3 ± 0.2 2.2 ± 0.2 2.2
3.3 ± 0.3 3.9 ± 0.4 3.3
3.2 ± 0.4 4.5 ± 0.4 4.0
2.2 ± 0.2 1.9 ± 0.1 2.1
2.8 ± 0.2 3.4 ± 0.4 3.1
2.9 ± 0.3 3.1 ± 0.3 3.1
2.5 ± 0.2 2.7 ± 0.2 2.5
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the RMSF profile, such as enhanced fluctuations in the activation
loop, and the a-helix mentioned above, while a reduction in the
fluctuation of residues in the b-subunit is observed. In contrast,
the RMSF profiles remain generally unaltered upon subsequent
binding of ATP, as noted in the comparison of the results obtained
for holo and holo + ATP systems.Fig. 2. Representation of the first essential motion derived from the ED analysis of the
holo + ATP complexes with A-769662 and SC4 determined from the snapshots sampled al
by residues 100–110 and 220–229 in the a-subunit in green, and the CBM domain in mag
referred to the web version of this article.)
33993.2. Dynamics of AMPK complexes
The dynamical behavior of proteins exerts a major role in their
function at multiple time scales, affecting processes such as
enzyme catalysis [48–50]. Here the effect of activator on the
dynamics of AMPK was examined by analyzing the essential
dynamics (ED) and conformational entropy of the protein back-protein backbone for A) the a2b1 and a2b2 apo species, and their B) holo and C)
ong the last 500 ns of simulations. The P-loop is shown in yellow, the helices formed
enta. (For interpretation of the references to colour in this figure legend, the reader is
E. Aledavood, A. Forte, C. Estarellas et al. Computational and Structural Biotechnology Journal 19 (2021) 3394–3406bone in conjunction with the cross-correlation mapping at the resi-
due level.
ED was used to characterize the effect of ligand binding on the
major motions of the protein backbone. For the two apo species,
the first essential motion involves a concerted bending that brings
the core of a-helices in the a-subunit and the b-sheets in the b-
subunit closer and then moves them apart (Fig. 2A). Nevertheless,
there are slight differences in the extent of this motion for certain
structural elements, such as the deformation of the CBM unit and
the P-loop, which is located at the interface of ADaM and ATP-
binding sites (Fig. S3). On average, the first motion accounts for
41% of the structural variance in a2b1, and 31% in a2b2. The differ-
ence in the conformational variance observed in the first essential
motion is also reflected in the cumulative variance explained by
the three main essential motions, which amounts to 66% and 57%
of the structural flexibility in a2b1 and a2b2, respectively
(Fig. S4). This highlights the significant contribution of the first
essential motion to the conformational flexibility of the AMPK
complexes. On the other hand, the conformational entropy of the
two apo forms is basically the same (~19 kcal K1 mol1; Table 3).
Binding of activator and ATP reduces the conformational vari-
ance originated from the first three essential motions in a2b1 com-
plexes with A-769662 and SC4 (from 66% to 58% to 47% from apo to
holo to holo + ATP in the case of A-769662), reflecting the trend
observed for the first essential motion (Fig. S4). This leads to a
progressive decrease in the conformational entropy of the protein
skeleton (Table 3). In contrast to the apo species, the activator pro-
motes the synchronous motion of the P-loop and the CBM domain,
which bends toward the a-subunit (Fig. 2 and S5). Subsequent
binding of ATP in the kinase domain, however, reduces the overall
flexibility of the protein, especially regarding the P-loop and most
of the helices in the a-subunit, but also elements of the b-subunit
proximal to the ADaM site, reflecting the synergy between activa-
tor and ATP in increasing the stiffness of the AMPK complex.
The dynamical behaviour observed for a2b1 is less regular in
a2b2. Thus, the structural variance explained by the first essential
motion in the apo form remains unaltered or is even slightly
increased in the presence of the activator (Fig. S4). Furthermore,
although the activator increases the conformational flexibility of
the P-loop, the response of other structural elements is more vari-
able, as noted for instance in the deformations observed for certain
helices in the a-subunit, such as those formed by residues Glu100-
Arg110 and Pro220-Gly229, or the b-sheets in the N-terminus of
the b-subunit (Fig. 2 and S5), this effect being generally more pro-
nounced for SC4-bound complexes. The lack of a uniform, consis-
tent pattern of structural flexibility is also found in theTable 3
Entropy values at infinite simulation time (S1; kcal K1 mol1) determined for the
protein backbone of apo, holo and holo + ATP systems of AMPK. Changes in
conformational entropy (DS1) are determined relative to the apo species. Values
averaged for the three independent simulations run for the systems (standard
deviation in parenthesis).
Species a2b1 a2b2
S1(apo) 19.1 (0.2) 18.8 (0.3)
A-769662
S1(holo) 18.9 (0.1) 18.6 (0.2)
DS1(holo) 0.2 0.2
S1(holo + ATP) 18.5 (0.1) 18.4 (0.1)
DS1(holo + ATP) 0.6 0.4
SC4
S1(holo) 18.8 (0.4) 19.0 (0.2)
DS1(holo) 0.3 +0.2
S1(holo + ATP) 18.5 (0.3) 19.0 (0.6)
DS1(holo + ATP) 0.6 +0.2
3400holo + ATP systems, as well as in the distinct changes observed
in the conformational entropy for A-769662 and SC4 (Table 3).
To complement the preceding results, dynamical cross-
correlation (DCC) analysis was performed to examine the corre-
lated motions of residues in AMPK complexes. Results for a2b1
and a2b2 complexes interacting with A-769662 are shown in
Fig. 3. The overall trends are similar to those obtained for the
SC4-bound systems (Fig. S6). Binding of activator and ATP pro-
motes a general decrease in the dynamical correlation of residues.
This is reflected in the weakening of the correlated regions in the
DCC map (Fig. 3B-C and S6B-C), as one may notice a progressive
reduction in the number and intensity of the areas that exhibit a
pronounced correlation (shown in yellow and blue for highly cor-
related and anticorrelated fluctuations between residues in plots B
and C, which correspond to holo and holo + ATP species). Further-
more, one may note that this effect is more noticeable for the a2b1
isoform. The apo systems (Fig. 3A and S6A) exhibit a correlation
between the P-loop, the a-helix formed by residues 100–110 and
the aC-helix (as noted by the yellow marks), which pertain to
the a-subunit. In turn, they are correlated with the C-interacting
helix in the b-subunit. Binding of activator and ATP reinforces
the correlation between the motion of the CBM domain and the
P-loop (black square in Fig. 3 and S6). This effect is more pro-
nounced for the a2b1 isoform, which shows a more consistent
dynamical response to activator binding, as noted in similarity
indexes of 0.91 (A-769662) and 0.84 (SC4) obtained from the
comparison of DCC matrices derived for the simulations of a2b1
(Table S2), whereas the similarity is reduced to 0.75 for a2b2.
Remarkably, this difference is even larger for the dynamical cou-
pling between a- and b-subunits, as noted in similarity indexes
of 0.89 (A-769662) and 0.83 (SC4) for a2b1, which are reduced
to 0.59 and 0.66 for a2b2, respectively.
Despite the overall gross similarity in the dynamical behavior of
both a2b1 and a2b2 isoforms, the preceding results reveal the
occurrence of subtle differences between b1- and b2-containing
AMPK complexes. In particular, the results suggest that the a2b2
complex has a larger resilience to the structural modulation
exerted by the activator, whereas the a2b1 isoform is more sensi-
tive to the conformational adaptation induced upon activator bind-
ing to the ADaM site, enhancing the stiffness of protein backbone
for the b1-containing complex, especially for A-769662.
3.3. Pre-organization of the ATP-binding site
To examine the implications of the differences in the dynamical
response to binding of activator, we determined the structural
resemblance of the ATP-binding site along the simulations
obtained for apo, holo, and holo + ATP systems. To this end, we
decided to use the average structure of the holo + ATP complex
as reference, this choice being motivated by two major reasons:
i) the large structural resemblance of the energy-minimized aver-
aged holo + ATP structures for a2b1 and a2b2 complexes with A-
769662 and SC4 (see Fig. 1A), and ii) the notable reduction in the
conformational flexibility of the ATP binding site for the
holo + ATP species (see plots C in Fig. 2).
For the holo + ATP species, the residues in the ATP-binding site
sample a reduced conformational space, with a peak generally cen-
tred at a positional RMSD of 1.0–1.6 Å for a2b1 and a2b2 isoforms
(Fig. 4). In contrast, the apo form exhibits a wider distribution,
showing either a single or a bimodal RMSD profile, with values
ranging from 1.0 to 5.5 Å. This reflects that the ATP-binding site
in the apo species is more conformationally mobile than in the
holo + ATP state. Due to this conformational flexibility, the ATP-
binding site can often adopt conformations close to those popu-
lated in the holo + ATP state, but also visit more dissimilar confor-
mational regions. The most distinctive features emerge from the
Fig. 3. Dynamic cross-correlation (DCC) matrices for A) apo, B) holo and C) holo + ATP complexes of (left) a2b1 and (right) a2b2 with A-769662. The x- and y-axis denote the
numbering of residue in the a- and b-subunit. The residues pertaining to the a- and b-subunits are indicated at the bottom of the plot (green and blue lanes for a- and b-
subunits, respectively). Specific regions of AMPK are highlighted with squares at the top of the plot: P-loop (pink), aC-helix (blue), activation loop (A-loop; cyan), CBM unit
(orange) and C-interacting helix (C-int; green). Regions colored in yellow/blue show high correlated/anticorrelated fluctuations. The black square in the plots highlights the
motion between the CBM domain and the P-loop. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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binding of the activator shifts the holo distribution toward the
holo + ATP profile. This is clearly observed in the complexes with
A-769662, where the peak in the apo distribution located at
2.8 Å is shifted to 1.5 Å for the holo species, and SC4, where the
broad distribution observed for the apo species is converted into
a narrower band that matches well the distribution of the
holo + ATP system (Fig. 4). In contrast, the RMSD profile obtained
for a2b2 complexes reveals that the activator leads to structures
where the ATP-binding site has less resemblance to the
holo + ATP system (Fig. 4). The analysis of the distinct structural
elements that shape the ATP-binding site shows that the differ-
ences observed for a2b1 and a2b2 holo species mainly arise from3401the conformational changes of the P-loop rather than from residues
in the helical domain of the a-subunit (data not shown), suggesting
that the activator is more effective in inducing the remodeling of
the P-loop toward active-like conformations in b1-containing
complexes.
These results are in agreement with the larger activation
exerted by A-769662 for the a2b1 isoform, while a weaker effect
is observed for a2b2 isoform (Table 1), supporting the hypothesis
that the activator acts as a molecular glue in a2b1 that connects
the fluctuations of the CBM domain in the b-subunit with the
P-loop, facilitating the arrangement of key structural elements,
particularly the P-loop, toward conformations favouring the bind-
ing of ATP. These trends can be extrapolated to SC4, although the
Fig. 4. Distribution of the positional deviation (RMSD; Å) of the structures sampled along the trajectories run for apo (red), holo (blue), and holo + ATP (orange) for the
residues that shape the ATP-binding site (residues a22–a32, a42–a46, a75–a79, a142–a147, and a153–a157). A total of 60,000 snapshots taken from the last 500 ns of MD
simulations were considered for each system in the analysis. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of
this article.)
E. Aledavood, A. Forte, C. Estarellas et al. Computational and Structural Biotechnology Journal 19 (2021) 3394–3406difference between a2b1 and a2b2 is less apparent compared to A-
769662 (Table 1).
3.4. Structural basis of the selective b1-containing AMPK activation by
A-769662 and SC4
Accordingly, to explore the structural basis of the selective acti-
vation of b1-containing AMPK by A-769662, we examined the net-
work of interactions formed between the activator with both P-
loop and CBM unit, paying attention to the occurrence of residue
substitutions between b1- and b2-isoforms (Fig. S7).
At the inner edge of the ADaM site in holo a2b1, bArg83 consis-
tently forms a salt bridge with aAsp88 (average distance of 3.2 ± 0.
2 Å from the guanidinium unit to the carboxylate group), which is
assisted by a hydrogen bond between aAsp88 and the thienopyri-
done ring of A-769662 (2.8 ± 0.2 Å; Fig. 5A). At the outer edge of
the ADaM site, the phosphorylated bSer108 (bSer108p) adopts
two arrangements that enable interactions with aLys31 (4.3 ± 1.
4 Å) and aLys29 (3.5 ± 0.8 Å). Binding of A-769662 is also assisted
by hydrophobic contacts of the ligand with aVal11, aLeu18, aIle46,
aPhe90 and bVal113 (not shown in Fig. 5A for the sake of clarity in
the graphical display), forming a tightly packed cage around A-
769662.
This interaction pattern is drastically altered in holo a2b2, as
noticed in the loss of the b2Arg82-aAsp88 interaction (N. . .O
distance > 7.1 Å; Fig. 5B). This can be attributed to the replacement
b1Asn111 ? b2Asp111, as this latter residue competes with
aAsp88 in forming electrostatic interactions with b2Arg82. In fact,
b2Arg82 adopts a distinct conformation that enables a direct salt
bridge with bSer108p, which maintains a fixed orientation in con-
trast to the dual arrangement found in holo a2b1. This weakens the3402role of A-769662 in mediating the interaction between the CBM
domain and the P-loop. Indeed, the impact of the
b1Asn111 ? b2Asp111 change is reflected in the major interaction
pathways identified fromWISP analysis for the two holo species. In
holo a2b1, the CBM domain and the P-loop are connected via three
pathways, implying in one case the passage through bSer108p, and
the involvement of the ligand, especially via the triad bArg83-aA
sp88-A-769662, in the other two (Fig. 5C; close up view shown
in Fig. S8). In contrast, only the bSer108p pathway is found in holo
a2b2, which suggests a weaker ability of A-769662 to act as a glu-
ing molecule between the b2-subunit and the P-loop compared to
holo a2b1 (Fig. 5D; see also Fig. S8).
Compared to A-769662, SC4 exhibits a mild preference for acti-
vation of b1-containing AMPK (Table 1), raising questions about
the interaction network formed by SC4 in the holo species. The
analysis reveals a more complex scenario, since two arrangements
are found for bArg83 (bArg82) in holo a2b1 (a2b2) (Fig. 6A-B). In
one case, bArg83 (bArg82) forms a salt bridge with aAsp88 (3.1 ±
0.2 Å), which also accepts a hydrogen bond from the imidazo
[4,5-b]pyridine ring of SC4 (3.4 ± 0.2 Å), whereas aLys29 interacts
with bSer108p (3.3 ± 0.7 Å) and is hydrogen bonded with the
pyridine-like/imidazole-like nitrogen atoms of SC4 (3.6 ± 0.6 Å,
Fig. 6A-B, residues in cyan). Alternatively, bArg83 (bArg82) inter-
acts with bSer108p (Fig. 6A-B, residues in grey), forming an addi-
tional cation-p interaction with the imidazo[4,5-b]pyridine ring,
which in turn is hydrogen bonded to aLys29. Remarkably, in holo
a2b2 this latter arrangement of bArg82 is also stabilized by the
interaction with bAsp111.
In contrast to A-769662, the occurrence of this dual interaction
pattern reflects the electrostatic influence of the carboxylate group
present in SC4, which would facilitate the adoption of the two
Fig. 5. Representation of selected interactions between the CBM, P-loop and A-769662 in holo A) a2b1 and B) a2b2. The two arrangements of bSer108p in holo a2b1 are
shown in cyan and grey colors (P-loop in yellow). A-769662 is shown as coloured (carbon atoms in magenta) sticks in the ADaM site, and a 2D representation of the chemical
structure is shown for the sake of clarity. Selected interactions between residues are highlighted as dashed lines. Major interaction networks obtained from WISP analysis for
C) a2b1 and D) a2b2 systems (close up views available in Fig. S8). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version
of this article.)
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bridge with aAsp88 in holo a2b1, the CBM unit and the P-loop
are then connected by two main pathways, which reveal the
involvement of either bSer108p or the triad bArg83-SC4-aLys29
(Fig. 6C left; close up view shown in Fig. S8). However, when the
bArg83-aAsp88 salt bridge is lost (Fig. 6C right, and Fig. S8), the
CBM and P-loop are linked via bAsn111, the phosphate unit of
bSer108p and aLys31 as well as via direct interactions between
bArg83 and the bSer108p phosphate unit. The interaction network
observed in holo a2b2 exhibits a more diverse pattern, likely
reflecting the larger flexibility observed in this species relative to
holo a2b1. Thus, besides the bArg82-SC4-aLys29 triad, which
defines the main pathway, an alternate network involves the cor-
related motion of the pair formed by aLys29 and the bSer108p
phosphate unit, whereas the loss of the bArg82-aAsp88 salt bridge
primarily reinforces the connection via bSer108p, which is also
assisted by another path where bArg82 interacts with both
bAsp111 and the bSer108p phosphate group. Compared to the
behavior found for A-769662 bound to a2b1 and a2b2 (Fig. 5C
and D), these findings provide a basis to understand the mild selec-
tivity of SC4 between a2b1 and a2b2 isoforms.34034. Discussion and conclusion
Unveiling the molecular factors that underlie the structure–
function relationships of AMPK isoforms is necessary to rationalize
the tissue-dependent expression of AMPK complexes, enabling the
design of tailored compounds active against specific metabolic dis-
orders. This question, however, is challenged by the high structural
and dynamical behavior observed for a2b1 and a2b2 complexes,
although our results have revealed subtle differences in the
dynamical response of AMPK to the binding of activators, showing
a larger mechanical sensitivity of the a2b1 complex and a larger
resilience of the a2b2 species, especially regarding modulation
by A-769662.
The different interaction networks observed upon binding of A-
769662 to a2b1 supports the effective role of the activator in
assisting synergistically the fluctuations of the CBM unit and the
P-loop, facilitating the adoption of pre-organized conformations
that favor the binding of ATP, shifting the enzyme towards an
active state. This effect is weakened in holo a2b2, which results
in decreased efficacy of A-769662 in acting as a molecular glue
between the CBM unit and the P-loop, making the enzyme less
Fig. 6. Representation of selected interactions between the CBM, P-loop and SC4 in holo A) a2b1 and B) a2b2. The distinct conformational arrangements are shown in cyan
and grey colors (P-loop in yellow). SC4 is shown as coloured (carbon atoms in orange) sticks in the ADaM site, and a 2D representation of the chemical structure is shown for
the sake of clarity. Selected interactions between residues are highlighted as dashed lines. Major interaction networks obtained from WISP analysis for C) a2b1 and D) a2b2
systems (close up views available in Figs. S9 and S10). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
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that this effect might be related, at least in part, to the occurrence
of the b1Asn111 ? b2Asp111 substitution, which would perturb
the pattern of interactions formed by the activator upon binding
to the ADaM site.
Disentangling the functional relevance of the perturbation
caused by the b1Asn111 ? b2Asp111 substitution is challenging
in light of the presence of other substitutions present in b1 and
b2 isoforms, which collectively may dictate the sensitivity of the
AMPK complex to direct activators. In particular, changes of resi-
dues b1Phe82, b1Leu93 and b1Leu103 to b2Ile81, b2Ile92 and
b2Ile103, respectively, which are embedded in a hydrophobic clus-
ter in the CBM unit (Fig. S11), result not only in enlarged fluctua-
tions of the hydrophobic core in holo a2b2, as the RMSF of these
residues increases on average from 1.27 ± 0.05 (a2b1) to
1.57 ± 0.14 (a2b2) Å, but also to residue rearrangements, such as
the conformational change observed for b2Tyr125 and b2Phe96,
leading to local remodeling of the CBM unit (Fig. S12). At this point,
it is worth noting that previous experimental studies reported that
the double substitution b1Phe82 ? Ile and b1Leu93 ? Ile sufficed
to annihilate the activation of a1b1c1 by MT47-100 [31]. On the
other hand, the linkage between bSer108p in the CBM unit and
residues aLys29 and aLys31 in the P-loop is reinforced by sec-
ondary interactions formed by other residues, such as b1Thr1063404and b1Arg107, which are changed to b2Ile106 and b2Lys107,
respectively. b1Arg107 forms a cation-p interaction with bPhe112
(4.3 ± 0.9 Å), supplemented by a hydrogen bond with the carbonyl
oxygen of bGly88. These interactions are lost in holo a2b2, where
b2Lys107 is exposed to the aqueous solvent. Moreover, b1Thr106 is
transiently hydrogen bonded to the carbonyl oxygen of aGly9,
favouring the interaction of aArg10 with aGlu34, which is located
at the end of the P-loop.
In the case of SC4, the resemblance of the dual interaction net-
works that connect the CBM unit and the P-loop via bSer108p and
particularly the bArg83-SC4-aLys29 triad provides a basis to
understand the mild selectivity between b1- and b2-containing
AMPK. This can be attributed to the electrostatic influence of the
carboxylate group present in SC4, which would facilitate the adop-
tion of the two arrangements of bArg83 (bArg82), tempering the
effect of the b1Asn111 ? b2Asp111 substitution. Noteworthy, this
may explain the slightly larger activation observed for
b1-containing AMPK by 991, keeping in mind the similar scaffold
of SC4 and 991, particularly regarding the presence of the carboxy-
late group (Table 1). On the other hand, these findings explain the
moderate impact observed experimentally for the mutation
bSer108 ? Ala, which increase the EC50 value for SC4 activation
by only ~ 4-fold (determined for a1b1c1) [29], since this substitu-
tion can be counterbalanced by the bArg83-SC4-aLys29 network.
E. Aledavood, A. Forte, C. Estarellas et al. Computational and Structural Biotechnology Journal 19 (2021) 3394–3406Further, this also explains the ~ 6-fold reduction in the activation
potency (determined for a2b2c1) found upon substitution of the
SC4 pyridine-like nitrogen in the imidazo[4,5-b]pyridine ring for
carbon [24], since this replacement should annihilate the hydrogen
bond formed between SC4 and aLys29, altering the triad aLys29-
imidazo[4,5-b]pyridine-aAsp88. At this point, let us note that this
triad cannot be found in the X-ray structure of the complex
between a2b2c1 and SC4, since the crystallization experiment
was performed at pH 6.0, where the imidazo[4,5-b]pyridine was
protonated, leading to a different interaction pattern.
In summary, we were able to discern key molecular features
that mediate the selective activation of a2b1 and a2b2 isoforms,
explaining the different selectivity of A-769662 and SC4. These
findings pave the way to understand the ’mechanically sensitive’
role of specific residues in the ADaM site that are able to modulate
the direct activation mechanism of b1- and b2-containing AMPK
complexes. Further studies will be valuable to discern the struc-
tural basis of the different sensitivity of AMPK complexes formed
by distinct a-subunits to the regulation by direct activators, thus
enabling the design of tissue-selective modulators of this impor-
tant energy sensor.Funding
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